Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population
Background Between 2015 and 2019, when 62% of Belgian adults aged ≥65 years were vaccinated with standard quadrivalent influenza vaccines, influenza caused an average of 3,905 hospitalizations and 347 premature deaths per year in older adults. The objective of the present analysis was to estimate th...
Saved in:
Main Authors: | Sophie Marbaix (Author), Nicolas Dauby (Author), Joaquin Mould-Quevedo (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom
by: Michele A. Kohli, et al.
Published: (2021) -
Cost-effectiveness for high dose quadrivalent versus the adjuvanted quadrivalent influenza vaccine in the Italian older adult population
by: Filippo Rumi, et al.
Published: (2023) -
Modelling the population-level benefits and cost-effectiveness of cell-based quadrivalent influenza vaccine for children and adolescents aged 6 months to 17 years in the US
by: Stephen I. Pelton, et al.
Published: (2024) -
Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea
by: Youngji Song, et al.
Published: (2024) -
A clinical and economic assessment of adjuvanted trivalent versus standard egg-derived quadrivalent influenza vaccines among older adults in the United States during the 2018-19 and 2019-20 influenza seasons
by: Myron J. Levin, et al.
Published: (2024)